Page 13: Canadian Immunization Guide: Part 1 - Key Immunization Information

Recommended Immunization Schedules

General Recommendations

Administration of vaccines in accordance with the immunization schedules summarized in the following tables will provide optimal protection from vaccine preventable diseases for most individuals. However, modifications of the recommended schedule may be necessary due to missed appointments or illness. In general, interruption of an immunization series does not require restarting the vaccine series, regardless of the interval between doses. Individuals with interrupted immunization schedules should be vaccinated to complete the appropriate schedule for their current age. Refer to Timing of Vaccine Administration in Part 1 and vaccine-specific chapters in Part 4 for additional information.

Similar, but not identical, vaccines may be available from different manufacturers; therefore, it is useful to review the relevant vaccine-specific chapters in the Canadian Immunization Guide as well as the manufacturer's product leaflet or product monograph before administering a vaccine. Refer to Principles of Vaccine Interchangeability in Part 1 for information about the interchangeability of similar vaccines from different manufacturers. Product monographs are periodically updated; it is a best practice to consult the information contained within the product monographs available through Health Canada's Drug Product Database.

Table 1: Routine Childhood Immunization Schedule, Infants and Children (birth to 17 years of age)

Table 1: Routine Childhood Immunization Schedule, Infants and Children (birth to 17 years of age)
VaccineFootnote * Age
Birth 2 mos 4 mos 6 mos 12 mos 15 mos 18 mos 23 mos 2 years 4 years 5 years 6 years 9 years 12 years 14 years 15 years 16 years 17 years
DTaP-IPV-Hib
or
DTaP-HB-IPV-Hib
Table 1 - Footnote A
or Table 1 - Footnote B
1st dose
Table 1 - Footnote A
or Table 1 - Footnote B
2nd dose
Table 1 - Footnote A
or Table 1 - Footnote B
3rd dose
Table 1 - Footnote A
or 4th dose
Generally at 18 months of age
DTaP-IPV
or
Tdap-IPV
Table 1 - Footnote C
Tdap Table 1 - Footnote D
Rot Table 1 - Footnote E
2 or 3 doses
Complete series before 8 months
Pneu-C-13 Table 1 - Footnote F Table 1 - Footnote F
Men-C-C Table 1 - Footnote [G]
According to P/T schedule
Table 1 - Footnote G
Generally at 12 months
Men-C-C
or
Men-C-ACYW
Table 1 - Footnote H
MMR and Var Table 1 - Footnote I + Table 1 - Footnote J Table 1 - Footnote I + Table 1 - Footnote J
OR
MMRV Table 1 - Footnote K Table 1 - Footnote K
Generally at 4-6 years
HB Table 1 - Footnote L
3 doses
OR
HB Table 1 - Footnote M
2 or 3 doses
HPV Table 1 - Footnote N
2 or 3 doses
OR
HPV Table 1 - Footnote O
3 doses
Inf Table 1 - Footnote P
1 or 2 doses
Recommended annually
Table 1 - Footnote P
1 dose
Recommended annually

Table 2: Recommended Immunization Schedule, Children (less than 7 years of age), NOT Previously Immunized as Infants

Table 2: Recommended Immunization Schedule, Children (less than 7 years of age), NOT Previously Immunized as Infants
VaccineFootnote * 1st visit Time after 1st visit 6-12 mos
after last dose
4 weeks 8 weeks 3 mos 4 mos 6 mos
DTaP-IPV-Hib
or
DTaP-IPV
Footnote A Footnote A Footnote A Footnote A Footnote [B]
Pneu-C-13 Footnote [C] Footnote [C]
Men-C-C Footnote D
MMR Footnote E Footnote E
Var Footnote F Footnote F
OR
MMRV Footnote G Footnote G
HB Footnote [H] Footnote [H] Footnote [H]
Inf Footnote I Footnote I

Table 3: Recommended Immunization Schedule, Children (7 to 17 years of age), NOT Previously Immunized

Table 3: Recommended Immunization Schedule, Children (7 to 17 years of age), NOT Previously Immunized
VaccineFootnote * 1st visit Time after first visit 6-12 mos after last dose 10 yrs after last dose
4 weeks 8 weeks 3 mos 6 mos
Tdap-IPV
Tdap
Footnote A Footnote A Footnote A Footnote B
Men-C-C Footnote [C]
7-11 years of age
OR
Men-C-C
or
Men-C-ACYW
Footnote D
12-17 years of age
MMR Footnote E Footnote E
Var Footnote F Footnote F
OR
MMRV Footnote G
7-12 years of age
Footnote G
HB Footnote H Footnote [H] Footnote H
HPV Footnote I
9-14 years of age
Footnote I
OR
HPV Footnote I
9-14 years of age
3 doses
OR
HPV Footnote J
15-17 years of age
3 doses
Inf Footnote K
7-8 years of age
Footnote K
OR
Inf Footnote K
9-17 years of age

Table 4: Additional Recommended Immunizations, Children (birth to 17 years of age), Considered AT RISK due to Underlying Medical Conditions

Table 4: Additional Recommended Immunizations, Children (birth to 17 years of age), Considered AT RISK due to Underlying Medical Condition
VaccineFootnote * Age
Birth 2 mos 6 mos 12 mos 15 mos 18 mos 23 mos 2 years 3 years 5-8 yrs 9-17 yrs
Hib Footnote A
1 dose
Pneu-P-23 Footnote B
1 dose + 1 booster dose if at highest risk
Pneu-C-13 Footnote C Footnote [C]
If not previously received
Men-C-ACYW Footnote D
2, 3 or 4 doses + additional booster doses
4CMenB Footnote E
2, 3 or 4 doses + additional booster doses
HA Footnote F
2 doses
HB Footnote G
3 or 4 doses
Inf Footnote H
1 or 2 doses
Recommended annually
Footnote H
1 dose
Recommended annually

Table 5: Recommended Immunization Schedule, Adults (18 years of age and older), NOT Previously Immunized

Table 5: Recommended Immunization Schedule, Adults (18 years of age and older), NOT Previously Immunized
VaccineFootnote * 1st visit Time after 1st visit 6-12 mos after last dose 10 years after last dose
4 weeks 6 weeks 8 weeks 6 mos
Tdap-IPV
Td-IPV
Td
Footnote A Footnote B Footnote B Footnote C
MMR Footnote [D]
Var Footnote [E]
18-49 years of age
Footnote [E]
OR
HZV Footnote [F]
50 years of age and over
Pneu-P-23 Footnote [G]
Men-C-C
or
Men-C-ACYW
Footnote [H]
18-24 years of age
HPV Footnote I
3 doses
Inf Footnote J
Annually

Table 6: Recommended Immunizations, Adults (18 years of age and older), Previously Immunized

Table 6: Recommended Immunizations, Adults (18 years of age and older), Previously Immunized
VaccineFootnote * Age
18-26 years 27-49 years 50-59 years 60 years 65 years and older
Td Footnote A
1 dose every 10 years
Tdap Footnote B
1 dose
Pneu-P-23 Footnote C
1 dose
HZV Footnote D
1 dose
Inf Footnote E
Annually

Table 7: Additional Recommended Immunizations, Adults (18 years of age and older), Considered AT RISK

Table 7: Additional Recommended Immunizations, Adults (18 years of age and older), Considered AT RISK
VaccineFootnote * Age
18 years of age and older
Hib Footnote A
1 dose
IPV Footnote B
1 booster dose
MMR Footnote C
Second dose
Pneu-C-13 Footnote D
1 dose
Pneu-P-23 Footnote E
1 dose + 1 booster dose if at highest risk
Men-C-ACYW Footnote F
2 doses + booster doses
4CMenB Footnote G
2 doses
HA Footnote H
2 doses
HB Footnote I
3 or 4 doses
OR
HAHB Footnote J
3 or 4 doses
Inf Footnote K
Annually
Typh-I Footnote L
1 dose + booster doses if at ongoing risk
OR
Typh-O Footnote L
4 doses + booster doses if at ongoing risk
Rab Footnote M
3 doses + booster doses if required
Var Footnote N
2 doses
Report a problem or mistake on this page
Please select all that apply:

Privacy statement

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: